Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Sunshine Runhe Pharmaceutical is a specialized pharmaceutical manufacturer based in Chengdu, China, and operates as a wholly-owned subsidiary of Sichuan Kelun Pharmaceutical. The company is primarily engaged in the research, development, and large-scale production of chemical drugs, with a focus on therapeutic areas such as gastroenterology, cardiovascular disease, and infectious diseases. Its product portfolio features several key marketed drugs, including Rabeprazole Sodium for injection and various antibiotic formulations. The firm maintains state-of-the-art, GMP-certified manufacturing facilities that produce both oral solids and sterile injections. As a vital component of the Kelun Group, Sichuan Sunshine Runhe leverages the parent company's extensive R&D infrastructure and distribution network to reach patients nationwide. The company is committed to maintaining high quality standards while ensuring the accessibility of essential medicines in the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Sunshine Runhe Pharmaceutical.